NEULANDLAB - Neuland Laboratories

Neuland Laboratories

NEULANDLAB · Pharma > Pharmaceuticals & Drugs · Chairman: Davuluri Rama Mohan Rao · MD: Davuluri Saharsh Rao · Listing date: Oct. 14, 2008 · Employees: 1427 · Hyderabad · http://www.neulandlabs.com

Stock Price vs Company Growth

0.7%

16.4%

17.8%

6.7%

21.9%

69.7%

100.3%

10y

41.6%

all

35.2%

🤔 How to analyze this graph?

Last Traded Price

₹ 12,742 0.7%

10,060

15,219

Company Overview

Sales

1,533 Cr

Growth: 2.6%

Profit after Tax

223 Cr

Growth: -13.7%

Mid Cap

16,348 Cr

P/E: 54.5x

Industry P/E: 30.4x

Fundamentals

Sales (Cr)	₹ 1,533
Growth	2.6%
EBITDA	24.7%
P/S	10.7x
Dividend	0.2%
P/E	54.5x
Book Value	₹ 1,121
PEG Ratio	20.5x
ROE	16.3%
P/B	11.3x

Shareholding Pattern

Institutions

Malabar India Fund Limited

9.95 %

Malabar Value Fund

4.29 %

Matthews India Fund

2.55 %

Icg Q Limited

1.76 %

Promoters

Ramamohan Rao Davuluri

24.97 %

Davuluri Vijaya Rao

4.78 %

Davuluri Sucheth Rao

2.63 %

Davuluri Saharsh Rao

1.98 %

Davuluri Rohini Niveditha Rao

1.27 %

Others

Mukul Mahavir Agrawal

2.34 %

Kedia Securities Private Limited

1.01 %

Iepf

0.21 %

Increase Decrease No change

Company Profile Detailed

Named after Father Nieuwland of Notre dame, Neuland Laboratories was incorporated in 1984 by Dr. D. R. Rao for the manufacture of Salbutamol Sulphate, with mere 40 employees.It has started its commercial production of Salbutamol Sulphate in the year 1986. It has since grown to become one of the most reliable API source for Pharma Industry with addition of more products in course of years.

Belongs to (21 Indices) view more

Investors (88)

icici.pr...

abg.capi...

ltr.focu...

Followers (2)

harit

nilofer4